Results 251 to 260 of about 610,993 (342)

The Function of the TGFβ Signaling Pathway in Connective Tissue Diseases: From Biology to Clinical Application. [PDF]

J Inflamm Res
Yuan S, Zhu W, Wang Y, Yu L.
europepmc   +1 more source

MIXED CONNECTIVE TISSUE DISEASE AND SILICOSIS: A DEVASTATING RELATIONSHIP CASE REPORT

Thiago Dantas Martins, Larissa Chediak Faraco, Thiago Ferreira da Silva, João Alves Gonçalves Neto, Maria Vitória Silva Pereira, Júlio R. Oliveira, L. Silva, Sarah Herculano Nóbrega, André Storti Martins, ISIS DE OLIVEIRA ALMEIDA, Bárbara Brito, Valdi de Lima Júnior, Laurinda Rosa Maciel, Manoel Ludgério Pereira Segundo Neto   +13 more
openalex   +1 more source

LOXHD1 and RHOB Expression by Monocytes Predicts Progressive Systemic Sclerosis associated Interstitial Lung Disease

Arthritis Care &Research, Accepted Article.
Objective A leading cause of death among scleroderma (SSc) patients, interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M Padilla, Robert Lafyatis, Kevin F Gibson, Christina Morse, Eleanor Valenzi, Xiaoping Chen, Xiaoyun Li, Yanwu Zhao, Yongseok Park, Dana Ascherman, Jonathan Minden, Robyn Domsic, Yingze Zhang, Daniel J Kass   +13 more
wiley   +1 more source

Screening for Pulmonary Hypertension in Connective Tissue Diseases: Literature Review and Multidisciplinary Consensus Statement. [PDF]

Anatol J Cardiol
Sarı A, Temiz Karadağ D, Erdoğan M, Yayla ME, Fırlatan Yazgan B, Dikkanoğlu Demirok B, Amikishiyev S, Yalçınkaya Y, İnanç M, Karcıoğlu O, Karakulak UN, Önen ZP, Akdeniz B, Okumuş G, Mutlu B, Küçükoğlu S, Akdoğan A.   +16 more
europepmc   +1 more source

Heterogeneity of Rheumatoid Arthritis–Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations With Disease Outcomes

Arthritis Care &Research, EarlyView.
Objective We aimed to identify unique disease trajectories within rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes. Methods We performed a cohort study of RA‐ILD within the Veterans Health Administration from 1999 to 2021.
Bryant R. England, Yangyuna Yang, Punyasha Roul, Tate M. Johnson, Scott M. Matson, Grant W. Cannon, Brian C. Sauer, Jeffrey R. Curtis, Joshua F. Baker, Ted R. Mikuls   +9 more
wiley   +1 more source

Counseling of Patients in Various Connective Tissue Disorders Presenting to Dermatology Outpatient Department. [PDF]

Indian Dermatol Online J
Garg S, Gowda SK, Behera B.
europepmc   +1 more source

Pulmonary Hypertension in Connective Tissue Disease

, 1996
Reiji Kasukawa
openalex   +2 more sources

Effectiveness and safety of baricitinib for juvenile idiopathic arthritis associated uveitis or chronic anterior antinuclear antibody positive uveitis

Arthritis Care &Research, Accepted Article.
Objectives Evaluate the efficacy and safety of baricitinib in paediatric patients with active JIA‐U or chronic anterior ANA‐positive uveitis, who had an inadequate response to MTX or bDMARDs. Methods JUVE‐BRIGHT was an open‐label, active‐controlled, Phase‐3 multicentre trial which utilized a novel design, including 1:1 randomization to an active ...
Athimalaipet V. Ramanan, Catherine M. Guly, Gabriele Simonini, Stuart Keller, Priyanka Sen, Thorsten Holzkaemper, Joana Araújo, Pierre Quartier   +7 more
wiley   +1 more source

Dendritic cell heterogeneity and its role in connective tissue diseases. [PDF]

Inflamm Regen
Yamada S, Suwa Y, Fujio K.
europepmc   +1 more source

Rethinking Strategies for a Pharmaceutical Approach to Pain Related to Connective Tissue–Related Raynaud Phenomenon in the United States

Arthritis Care &Research, EarlyView.
Objective There are no US Food and Drug Administration–approved therapies for Raynaud phenomenon (RP) in the United States. Clinical trials have been challenged by study design. Important advances in RP patient‐reported outcome measures and mechanistic quantification allow RP‐related pain characterization.
Tracy M. Frech, Charles G. Frech, W. David Merryman, Andrew Sternlicht, Justin Baba   +4 more
wiley   +1 more source